IRIS UniCatt

Bartoccioni, Emanuela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.029
EU - Europa 1.989
AS - Asia 1.700
SA - Sud America 360
AF - Africa 52
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 7.139
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.945
SG - Singapore 799
CN - Cina 422
DE - Germania 371
PL - Polonia 341
SE - Svezia 324
BR - Brasile 282
IT - Italia 268
FR - Francia 167
UA - Ucraina 148
VN - Vietnam 131
GB - Regno Unito 96
IE - Irlanda 86
IN - India 70
ID - Indonesia 51
FI - Finlandia 49
CA - Canada 48
JP - Giappone 44
RU - Federazione Russa 42
HK - Hong Kong 30
BD - Bangladesh 29
AR - Argentina 25
TR - Turchia 25
MX - Messico 22
BE - Belgio 20
IQ - Iraq 19
NL - Olanda 19
EC - Ecuador 14
ZA - Sudafrica 14
CO - Colombia 12
AT - Austria 11
CH - Svizzera 11
CI - Costa d'Avorio 11
PK - Pakistan 11
SA - Arabia Saudita 11
ES - Italia 10
VE - Venezuela 10
MA - Marocco 8
UZ - Uzbekistan 8
JO - Giordania 6
AU - Australia 5
CL - Cile 5
IL - Israele 5
IR - Iran 5
NO - Norvegia 5
PY - Paraguay 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
HN - Honduras 4
KZ - Kazakistan 4
LK - Sri Lanka 4
LT - Lituania 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
CZ - Repubblica Ceca 3
EG - Egitto 3
KG - Kirghizistan 3
MY - Malesia 3
RO - Romania 3
UY - Uruguay 3
AZ - Azerbaigian 2
BO - Bolivia 2
BY - Bielorussia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
GA - Gabon 2
KE - Kenya 2
KR - Corea 2
LB - Libano 2
LV - Lettonia 2
MD - Moldavia 2
NP - Nepal 2
OM - Oman 2
PE - Perù 2
AO - Angola 1
BH - Bahrain 1
DM - Dominica 1
GT - Guatemala 1
HU - Ungheria 1
JM - Giamaica 1
NI - Nicaragua 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
QA - Qatar 1
SC - Seychelles 1
SN - Senegal 1
SV - El Salvador 1
TJ - Tagikistan 1
TM - Turkmenistan 1
TO - Tonga 1
TW - Taiwan 1
Totale 7.139
Salva come PNG Salva come JPEG
Città #
Singapore 462
Ashburn 429
Chandler 394
Warsaw 306
San Jose 196
Jacksonville 97
Beijing 94
New York 89
San Mateo 88
Dublin 84
Los Angeles 74
Ann Arbor 64
Wilmington 61
Woodbridge 60
Cattolica 58
Cambridge 56
Chicago 53
Houston 53
Jakarta 48
Nanjing 48
Bremen 47
Ho Chi Minh City 46
Dearborn 44
Tokyo 42
Lauterbourg 41
Rome 41
Milan 39
North Bergen 36
Boston 35
Fairfield 32
Frankfurt am Main 32
Hanoi 31
Redwood City 28
Moscow 27
Seattle 27
Hong Kong 24
São Paulo 24
Kraków 23
Lawrence 23
Princeton 23
Santa Clara 23
Dallas 22
Marseille 22
Orem 21
Des Moines 20
Hefei 19
Atlanta 17
Buffalo 17
Denver 17
Montreal 17
Nanchang 17
Brussels 16
Munich 16
Düsseldorf 14
Chennai 13
Izmir 13
Paris 13
Abidjan 11
Brooklyn 11
London 11
Washington 11
Baghdad 10
Boardman 10
Helsinki 10
Lancaster 10
Stockholm 10
Columbus 9
Council Bluffs 9
Mountain View 9
Norwalk 9
Nürnberg 9
Rio de Janeiro 9
Shenyang 9
Amsterdam 8
Charlotte 8
Hebei 8
Manchester 8
San Francisco 8
Shanghai 8
Tianjin 8
Turku 8
Zhengzhou 8
Zurich 8
Brasília 7
Changsha 7
Chengdu 7
Hangzhou 7
Johannesburg 7
Phoenix 7
Quito 7
Toronto 7
University Park 7
Amman 6
Baltimore 6
Bexley 6
City of London 6
Dhaka 6
Genoa 6
Haiphong 6
Jeddah 6
Totale 4.124
Salva come PNG Salva come JPEG
Nome #
Association of the DNMT3B -579G>T polymorphism with risk of thymomas in patients with myasthenia gravis 340
Age-Related Sarcopenia: Diabetes of the Muscle? 340
Alterazioni delle risposte immuno-infiammatorie nei pazienti affetti da disturbo depressivo maggiore (Immune-inflammatory response changes in patients with major depressive disorder) 268
PTPN22 and myasthenia gravis: replication in an Italian population and meta-analysis of literature data 236
Test domiciliare per la diagnosi integrata di infezione da SARS-CoV-2 232
Novel path to IL-6 trans-signaling through thrombin-induced soluble IL-6 receptor release by platelets 221
T cell repertoire in DQ5-positive MuSK-positive myasthenia gravis patients 203
A Study of Inflammatory/Necrosis Biomarkers in the Fracture of the Femur Treated with Proximal Femoral Nail Antirotation 200
Poly-autoimmunity in patients with myasthenia gravis: A single-center experience 188
Flow Cytofluorimetric Analysis of Anti-LRP4 (LDL Receptor-Related Protein 4) Autoantibodies in Italian Patients with Myasthenia Gravis 186
Low reliability of anti-KIR4.183-120 peptide auto-antibodies in multiple sclerosis patients 185
Overcoming challenges in the diagnosis and treatment of myasthenia gravis 180
Overcoming challenges in the diagnosis and treatment of myasthenia gravis 177
A Genome-wide Association Study of Myasthenia Gravis 176
Remission of myasthenia gravis with MuSK antibodies during ruxolitinib treatment 173
Long-Lasting Rituximab-Induced Reduction of Specific—But Not Total—IgG4 in MuSK-Positive Myasthenia Gravis 169
IL-6 regulates MCP-1, ICAM-1 and IL-6 expression in human myoblasts. 165
Serological Immunoglobulin-Free Light Chain Profile in Myasthenia Gravis Patients 165
Myasthenia gravis with antibodies to MuSK: an update 159
HLA class II allele analysis in MuSK-positive myasthenia gravis suggests a role for DQ5. 155
Low reliability of anti-KIR4.183–120peptide auto-antibodies in multiple sclerosis patients 154
Skeletal muscle cells: from local inflammatory response to active immunity 151
Response to therapy in myasthenia gravis with anti-MuSK antibody 151
SNRI effective treatment does not restore changes of immune and inflammatory parameters in depressed patients 149
Characterization of B cells in muscle-specific kinase antibody myasthenia gravis 149
BAFF serum levels in myasthenia gravis: effects of therapy 141
Anti-AChR-negative myasthenia gravis: clinical and immunological features 141
Anti-acetylcholinesterase antibodies associate with ocular myasthenia gravis. 139
Pattern of ocular involvement in myasthenia gravis with MuSK antibodies 138
Disease specific enrichment of circulating let-7 family microRNA in MuSK+ myasthenia gravis 137
Overcoming challenges in the diagnosis and treatment of myasthenia gravis 130
Rituximab in myasthenia gravis: a "to be or not to be" inhibitor of T cell function 126
Management challenges in muscle-specific tyrosine kinase myasthenia gravis. 124
Early-onset myasthenia gravis: clinical characteristics and response to therapy 108
Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis 106
Anti-MuSK antibodies: Correlation with myasthenia gravis severity 105
IL-6, monocyte infiltration and parenchymal cells 101
Effect of pro-inflammatory/anti-inflammatory agents on cytokine secretion by peripheral blood mononuclear cells in rheumatoid arthritis and systemic lupus erythematosus 100
Anti-P110 autoantibodies identify a subtype of "seronegative" myasthenia gravis with prominent oculobulbar involvement 99
Neurophysiological and mitochondrial abnormalities in MuSK antibody seropositive myasthenia gravis compared to other immunological subtypes 95
Myasthenia gravis and associated autoimmune diseases 92
Identification of disease-specific autoantibodies in seronegative myasthenia gravis 87
Why Does an I.M. Immunization Work? 77
TGF-β1 and IL-10 modulate IL-1β-induced membrane and soluble ICAM-1 in human myoblasts 77
Immune-inflammatory response changes in patients with major depressive disorder 75
Constitutive and cytokine-induced expression of MHC and intercellular adhesion molecule-1 (ICAM-1) on human myoblasts 68
MHC class I, MHC class II and intercellular adhesion molecule-1 (ICAM-1) expression in inflammatory myopathies 52
TGF-β1 and IL-10 modulate IL-1β-induced membrane and soluble ICAM-1 in human myoblasts 52
Totale 7.242
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.881
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.881
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202167 0 0 0 0 0 0 0 0 0 10 47 10
2021/2022461 34 35 11 20 46 11 12 78 21 26 76 91
2022/20231.083 148 140 66 201 64 121 41 104 124 31 30 13
2023/2024599 16 134 24 43 32 78 37 50 10 20 68 87
2024/2025990 26 54 80 19 77 19 28 68 205 76 180 158
2025/20262.370 338 50 117 367 580 127 385 156 127 123 0 0
Totale 7.242